NCT00442143
Unknown
Phase 1
Treatment of Severe Limb Ischemia With Autologous Bonemarrow Derived Mononuclear Cells
ConditionsIschemia
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Ischemia
- Sponsor
- Odense University Hospital
- Enrollment
- 10
- Locations
- 1
- Primary Endpoint
- Transcutaneous oxygen pressure
- Last Updated
- 15 years ago
Overview
Brief Summary
The aim of the study is to investigate whether implantation of autologous bone marrow derived stem cells in ishemics limbs will improve vascularization
Detailed Description
10 patients with severe lower limb ischemia will be included in this pilote trial. Bonemarrow aspiration will be performed and and the monocuclear cells isolated an injected into the gastrocnemius. The patiens are followed for 4 months. Were trancutaneous oxygenpressure, ankel and toe blood pressure is measured.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Ankle blood pressure \< 70 mmgHG
- •Either pain at rest and/or ischemic wound
- •No possible surgical treatment
Exclusion Criteria
- •Infection
- •Malignant disease
Outcomes
Primary Outcomes
Transcutaneous oxygen pressure
1st toe blood pressure (strain gauge)
Ankle blood pressure
Wound healing
Pain
Secondary Outcomes
- amputation
- Infection
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 1
ALD-301 for Critical Limb Ischemia, Randomized TrialCritical Limb IschemiaPeripheral Arterial DiseasePeripheral Vascular DiseaseNCT00392509Aldagen20
Unknown
Phase 1
Autologous Bone Marrow Cell Treatment in Peripheral AtherosclerosisPeripheral Vascular DiseasesNCT00306085University of Naples20
Unknown
Phase 2
Autologous Bone Marrow Stem Cell Transplantation for Critical, Limb-threatening IschemiaPeripheral Vascular DiseaseDiabetic FootPeripheral Arterial Occlusive DiseaseLeg UlcerGangreneIschemiaNCT00434616Franziskus-Krankenhaus90
Completed
Phase 1
Autologous Bone Marrow Mesenchymal Stem Cells Transplantation for Articular Cartilage Defects RepairOsteoarthritisNCT01895413Alexandra Cristina Senegaglia10
Unknown
Phase 1
Treatment of Myocardial Infarction With Bone Marrow Derived Stem CellsAcute Myocardial InfarctionNCT00275977Odense University Hospital10